168 related articles for article (PubMed ID: 22447472)
1. New antithrombotic drugs: a revolution in stroke management.
Bryer A
Cardiovasc J Afr; 2012 Mar; 23(2):61-2. PubMed ID: 22447472
[No Abstract] [Full Text] [Related]
2. Risk versus benefit of non-vitamin K dependent anticoagulants compared to warfarin for the management of atrial fibrillation in the elderly.
Ogbonna KC; Jeffery SM
Drugs Aging; 2013 Jul; 30(7):513-25. PubMed ID: 23591934
[TBL] [Abstract][Full Text] [Related]
3. New antithrombotic drugs and European approval processes.
Marijon E; Fauchier L; Le Heuzey JY
Lancet; 2011 Aug; 378(9792):662-3. PubMed ID: 21856473
[No Abstract] [Full Text] [Related]
4. New antithrombotic drugs for atrial fibrillation: caution is needed.
Bell S; Nand J; Spriggs D
Lancet; 2012 Jan; 379(9813):e24; author reply e24-5. PubMed ID: 22284660
[No Abstract] [Full Text] [Related]
5. A new era of antithrombotic therapy in patients with atrial fibrillation.
Golwala H; Dib C; Tafur A; Abu-Fadel MS
Am J Med Sci; 2012 Aug; 344(2):128-35. PubMed ID: 22245946
[TBL] [Abstract][Full Text] [Related]
6. New oral anticoagulant in atrial fibrillation: are they comparable?
Kalodiki E; Lewis B; Fareed J
Int Angiol; 2012 Aug; 31(4):307-9. PubMed ID: 22801395
[No Abstract] [Full Text] [Related]
7. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation.
Harrington AR; Armstrong EP; Nolan PE; Malone DC
Stroke; 2013 Jun; 44(6):1676-81. PubMed ID: 23549134
[TBL] [Abstract][Full Text] [Related]
8. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly].
Páramo JA
Med Clin (Barc); 2013 Oct; 141(8):346-8. PubMed ID: 23831406
[No Abstract] [Full Text] [Related]
9. New alternative anticoagulants in atrial fibrillation: the move beyond warfarin.
Bhimani AA; Hong M
Rev Recent Clin Trials; 2013 Jun; 8(2):78-85. PubMed ID: 23859143
[TBL] [Abstract][Full Text] [Related]
10. [Differential therapy with the new anticoagulants, 5].
Stiefelhagen P
MMW Fortschr Med; 2013 May; 155(9):20. PubMed ID: 23951642
[No Abstract] [Full Text] [Related]
11. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
Bauer KA
Stroke; 2013 Jun; 44(6 Suppl 1):S38-40. PubMed ID: 23709725
[No Abstract] [Full Text] [Related]
12. Anticlotting therapy for atrial fibrillation: should you stay with the devil you know? Preventing stroke with warfarin (Coumadin) can be tricky. New anticlotting drugs can help if you accept certain trade-offs--and take them exactly as directed.
Harv Mens Health Watch; 2014 Apr; 18(9):1, 7. PubMed ID: 25108916
[No Abstract] [Full Text] [Related]
13. New agents to prevent strokes in nonvalvular atrial fibrillation.
Putney D; Pratt C
Methodist Debakey Cardiovasc J; 2012; 8(3):44-6. PubMed ID: 23227289
[TBL] [Abstract][Full Text] [Related]
14. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
Schneeweiss S; Gagne JJ; Patrick AR; Choudhry NK; Avorn J
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):480-6. PubMed ID: 22787066
[TBL] [Abstract][Full Text] [Related]
16. [Introduction].
Valle Bernad R
Rev Clin Esp; 2012 Jan; 212 Suppl 1():1-2. PubMed ID: 23117645
[No Abstract] [Full Text] [Related]
17. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
Miller CS; Grandi SM; Shimony A; Filion KB; Eisenberg MJ
Am J Cardiol; 2012 Aug; 110(3):453-60. PubMed ID: 22537354
[TBL] [Abstract][Full Text] [Related]
19. New oral anticoagulants in the management of venous thromboembolism: a major advance?
Sciascia S; Hunt BJ
Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):487-8. PubMed ID: 25150440
[No Abstract] [Full Text] [Related]
20. ["Xa-tra-xa": opportunities and open questions about new anticoagulants].
Beer JH
Praxis (Bern 1994); 2011 Aug; 100(16):947. PubMed ID: 21910293
[No Abstract] [Full Text] [Related]
[Next] [New Search]